G1 Therapeutics Ownership | Who Owns G1 Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

G1 Therapeutics Ownership Summary


G1 Therapeutics is owned by 38.21% institutional investors, 10.92% insiders, and 50.86% retail investors. Blackrock is the largest institutional shareholder, holding 5.91% of GTHX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.63% of its assets in G1 Therapeutics shares.

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock3.08M5.91%$7.03M
Geode capital management1.08M2.07%$2.46M
State street827.96K1.59%$1.89M
D. e. shaw767.07K1.47%$1.75M
Jacobs levy equity management463.59K0.89%$1.06M
Morgan stanley401.48K0.77%$915.38K
Bridgeway capital management398.04K0.76%$907.54K
Boothbay fund management349.10K0.67%$795.95K
Two sigma investments, lp308.82K0.59%$704.12K
Two sigma advisers, lp211.70K0.41%$482.68K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital12.25K0.49%$2.79M
Bridgeway capital management398.04K0.02%$907.54K
Boothbay fund management349.10K0.02%$795.95K
Virtu financial74.35K0.01%$170.00K
Jacobs levy equity management463.59K0.00%$1.06M
Panagora asset management177.05K0.00%$403.68K
Two sigma investments, lp308.82K0.00%$704.12K
D. e. shaw767.07K0.00%$1.75M
Two sigma advisers, lp211.70K0.00%$482.68K
Geode capital management1.08M0.00%$2.46M

Top Buyers

HolderShares% AssetsChange
Blackrock3.08M0.00%2.41M
State street827.96K0.00%666.85K
Geode capital management1.08M0.00%573.84K
Boothbay fund management349.10K0.02%349.10K
Morgan stanley401.48K0.00%226.14K

Top Sellers

HolderShares% AssetsChange
Vanguard group---2.49M
Woodline partners lp---1.36M
Renaissance---1.25M
Susquehanna group, llp---950.84K
Acadian asset management---928.21K

New Positions

HolderShares% AssetsChangeValue
Boothbay fund management349.10K0.02%349.10K$795.95K
Panagora asset management177.05K0.00%177.05K$403.68K
Nuveen asset management66.93K-66.93K$152.60K
Invesco35.71K-35.71K$81.42K
Alliancebernstein22.34K-22.34K$50.94K

Sold Out

HolderChange
Newedge advisors-200.00
Providence capital advisors-212.00
Lazard asset management-298.00
Planning capital management-320.00
Farther finance advisors-350.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241007.53%19,937,26539.36%385.00%6321.15%1713.33%
Mar 31, 2024933.33%14,305,88813.36%274.66%5215.56%15-48.28%
Dec 31, 20239021.62%12,619,70215.31%245.43%4528.57%2945.00%
Sep 30, 202374-12.94%10,944,376-29.44%212.35%356.06%20-33.33%
Jun 30, 202385-15.84%15,510,418-19.24%302.17%33-25.00%30-18.92%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.39M2.63%-
Arbitrage R1.31M2.49%1.31M
Vanguard Institutional Extnd Mkt Idx Tr659.13K1.25%594.00
Fidelity Canadian Large Cp Mlt Ast Bs O637.33K1.21%637.33K
Fidelity Small Cap Index505.64K0.96%-14.29K
Fidelity Extended Market Index265.36K0.50%6.65K
State St Russell Sm/Mid Cp® Indx NL Cl C263.37K0.50%61.62K
Bridgeway Ultra-Small Company228.04K0.43%206.90K
Vanguard Russell 2000 ETF198.71K0.38%5.00K
AltShares Merger Arbitrage ETF170.38K0.32%170.38K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 05, 2024Perry Andrew Chief Commercial OfficerSell$3.35K
Jul 05, 2024MURDOCK TERRY L Chief Operating OfficerSell$6.21K
Jul 05, 2024Malik Rajesh Chief Medical OfficerSell$6.21K
Jul 05, 2024Avagliano Mark Chief Business OfficerSell$6.62K
Jul 05, 2024Umstead John W. V Chief Financial OfficerSell$1.32K

Insider Transactions Trends


DateBuySell
2024 Q3-6
2024 Q2-7
2024 Q1-19
2023 Q4-2
2023 Q3-6

GTHX Ownership FAQ


Who owns the most shares of G1 Therapeutics?

G1 Therapeutics’s largest shareholders are Blackrock (3.08M shares, 5.91%), Geode capital management (1.08M shares, 2.07%), and State street (827.96K shares, 1.59%). Together, they hold 9.56% of G1 Therapeutics’s total shares outstanding.

Does Blackrock own G1 Therapeutics?

Yes, BlackRock owns 5.91% of G1 Therapeutics, totaling 3.08M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.03M$. In the last quarter, BlackRock increased its holdings by 2.41M shares, a 358.62% change.

Who is G1 Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is G1 Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.49% of its assets in 12.25K G1 Therapeutics shares, valued at 2.79M$.

Who is the top mutual fund holder of G1 Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of G1 Therapeutics shares, with 2.63% of its total shares outstanding invested in 1.39M G1 Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools